ALKS

#960
Alkermes plc - Ordinary Shares
42.2 0 USD
+5.66%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
42.10
42.81
Rango anual
25.16
42.81
Cambio diario
+5.66%
Variación mensual
+24.52%
Variación en los últimos 6 meses
+44.03%
Cambio anual
+39.50%
Cierres anteriores
39.9 4
Open
42.4 6
Mínimo
42.1 0
High
42.8 1
Volumen
2 644
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Noticias